BeStock  
Markets › Compare › ABUS vs YALA

ABUS vs YALA

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
ABUS · Arbutus Biopharma$4.08 ▼ 4.96%
YALA · Yalla$5.37 ▲ 0.15%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

668196110125Oct 9, '25Apr 9, '26Oct 7, '26
  • ABUS +0.5%
  • YALA -27.3%

Head to head

MetricABUSYALA
Price$4.08$5.37
Change today▼ 4.96%▲ 0.15%
Market cap$807.76M$815.02M
Return, 3 months-20.7%-0.6%
Return, year to date-15.2%-22.7%
Return, 1 year-2.5%-26.6%
P/E (TTM)5.27.1
P/B3.11.0
P/E percentile vs own 5y95th21st
Dividend yield––
Revenue growth (YoY, latest qtr)-90.6%-2.3%
Net profit growth (YoY)-303.8%-19.7%
Gross margin–67.8%
Operating margin81.1%30.9%
Net margin84.2%40.8%
Return on equity89.6%17.1%
Analyst target vs. price––
Analyst buy share––
RSI (14)3043
30-day volatility31.2%14.9%
Max drawdown, 1 year-25.9%-34.3%
Trend readStrong downtrendStrong downtrend
Analyst consensus––

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • YALA is the largest of the group by market value.
  • ABUS has returned the most over the past year.
  • ABUS carries the lowest trailing P/E.
  • YALA is growing revenue fastest.
  • ABUS keeps the most profit per dollar of sales.
  • YALA has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top